Whether you’re celebrating a funding round, research collaboration, FDA-approval, or commemorating a deal in the biotech space, you’ll find inspiration in the custom designs below.

Biotech IPO Tombstone

Lucite tombstone celebrating the initial public offering of biotech company Chiasma. The Massachusetts-based firm specializes in oral therapies for orphan diseases.

(6AEK859)
1 Image

Biotech Custom Lucite

Custom Lucite commemorating the private placement of shares issued by Cellectar. Madison, Wisconsin-based Cellectar focuses on developing cancer drugs and imaging tools.

(6ASHA20)
1 Image

Tombstone for Biotech Offering

Lucite tombstone commemorating a follow-on offering by WaferGen Biosystems. The Fremont, California-based company develops systems for genome analysis for use in the life science and pharmaceutical industries.

(4ASH556)
1 Image

Biotech Stock Offering Deal Toy

Financial tombstone commemorating two offerings of stock in Neurotrope BioScience. Headquartered in Newark, New Jersey, Neurotrope is a biopharmaceutical and diagnostics firm principally focused on the diagnosis and treatment of Alzheimer’s Disease.

1 Image

Biotechnology Custom Lucite

Corporate tombstone commemorating financing provided for Providence-based Nabsys. The life sciences and healthcare company focuses on applications for DNA sequencing research.

(3ANS085)
1 Image

Biotech IPO Deal Toy

Custom Lucite celebrating the IPO of Enzymotec, the Israeli developer of bio-functional, lipid-based compounds for medical and nutritional applications.

(4ATCOO5)
1 Image

Biotech Private Placement Deal Toy

Lucite tombstone marking the private placement of shares of DARA Biosciences. DARA is a specialty pharmaceutical company headquartered in Raleigh, North Carolina.

(4ASHOIG)
1 Image

Biotechnology Corporate Tombstone

Lucite tombstone marking an acquisition by Oxygen Biotherapeutics, now known as Tenax Therapeutics.

(4ASHOIF)
1 Image

Biotech Corporate Tombstone

Custom Biotech Corporate Tombstone recognizing the merger of Antitope and PolyTherics. Antitope was advised by London-based Ferghana Partners Group.

(3LMJOAQ)
1 Image

Biotech Deal Toys

Beginning on this page, you’ll find galleries with over 90 images of financial tombstones and deal toys from the biotech and life sciences space. You’ll find a number of custom designs playing off visual elements commonly associated with this space, including DNA strands, pills, lab beakers, periodic tables, as well as ones incorporating actual drug vials.

As you might also expect, you’ll see a number of deal toys involving internationally recognized firms and players. These include Takeda Pharmaceutical, Horizon Therapeutics, Gilead Sciences, Roche, Neurocrine, and Bayer. You’ll see as well tombstones commemorating transactions common to this sector involving these and other firms: joint ventures, licensing deals, and development and commercialization agreements.

But you’ll also notice a number of deals commemorated here that may involve far less familiar firms. These include the acquisition of a Dutch company focused on live-cell imaging analytics, and one of an Illinois-based gene therapy firm devoted to the treatment of a rare genetic disorder; the initial public offering of an Australian developer of radiopharmaceutical cancer therapies, and the IPO of a Norwegian biotech making use of marine compounds such as herring roe extract; early-stage funding for a Philadelphia gene engineering startup, and the IPO of an Israeli firm focused on medical applications for lipid-based compounds.

You’ll also notice in these galleries designs not related to any financial transaction. These celebrate a range of awards and employee recognition pieces honoring successful clinical trials, Food and Drug Administration (FDA) and New Drug Application (NDA) submissions, research collaborations and partnerships, and product development milestones.